|
|
|
|
| LEADER |
01707nam a2200301 u 4500 |
| 001 |
EB002002065 |
| 003 |
EBX01000000000000001164966 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
210907 r ||| eng |
| 245 |
0 |
0 |
|a Blood test for early diagnosis of Alzheimer's disease
|h Elektronische Ressource
|
| 260 |
|
|
|a [Stockholm]
|b SBU
|c 2012, 2012
|
| 300 |
|
|
|a 1 PDF file (4 pages)
|
| 505 |
0 |
|
|a Includes bibliographical references
|
| 653 |
|
|
|a Sensitivity and Specificity
|
| 653 |
|
|
|a Amyloid beta-Protein Precursor / analysis
|
| 653 |
|
|
|a Alzheimer Disease / blood
|
| 653 |
|
|
|a Biomarkers / blood
|
| 653 |
|
|
|a Alzheimer Disease / diagnosis
|
| 710 |
2 |
|
|a Statens beredning för medicinsk utvärdering (Sweden)
|
| 740 |
0 |
2 |
|a Blodprov för tidig diagnostik av Alzheimers sjukdom
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a SBU alert report
|
| 500 |
|
|
|a Summary of Blodprov för tidig diagnostik av Alzheimers sjukdom. 2012
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK285444
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a 1. Currently, no biomarkers in blood can be used to diagnose Alzheimer's disease.2. Of the four biomarkers studied, only platelet APP has shown differences between sick and healthy individuals. For the other biomarkers, the difference between sick and healthy people is insignificant.3. Large, independent studies are needed to determine whether platelet APP in blood tests could serve as a diagnostic tool.4. Studies using refined, highly sensitive measurement methods are needed to identify more biomarkers that could serve as diagnostic tools
|